MR [Mindray Medical International] S-8 POS:
[]
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray Announces Completion of Going Private Transaction Under the terms of the Merger Agreement, which was approved by the Company’s shareholders at an extraordinary general meeting held on February 26, 2016, each of the Company’s ordinary shares, consisting of Class A ordinary shares and Class B ordinary shares, par value HK$0.001 per share (each, a “Share”), issued and outstanding immediately] []
MR [Mindray Medical International] 6-K: Mindray Announces Completion of Going Private Transaction Under
[Mindray Announces Completion of Going Private Transaction Under the terms of the Merger Agreement, which was approved by the Company’s shareholders at an extraordinary general meeting held on February 26, 2016, each of the Company’s ordinary shares, consisting of Class A ordinary shares and Class B ordinary shares, par value HK$0.001 per share (each, a “Share”), issued and outstanding immediately] []
MR [Mindray Medical International] 6-K: Mindray Announces Shareholders’ Approval of Merger Agreement About
[Mindray Announces Shareholders’ Approval of Merger Agreement About Mindray Mindray (NYSE: MR) is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains its global headquarters in Shenzhen, China, its U.S. headquarters Mindray http://ir.mindray.com 4 For investor and media inquiries, please contact: In China: Cathy Gao Mindray Medical International Limited Tel: +86-755-8188-8023 cathy.gao@mindray.com Email: 5] []
